Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Debt (2020 - 2025)

Journey Medical's Non-Current Debt history spans 6 years, with the latest figure at $25.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt rose 1.6% year-over-year to $25.3 million, compared with a TTM value of $25.3 million through Dec 2025, up 1.6%, and an annual FY2025 reading of $25.3 million, up 1.6% over the prior year.
  • Non-Current Debt for Q4 2025 was $25.3 million at Journey Medical, up from $19.5 million in the prior quarter.
  • The five-year high for Non-Current Debt was $25.3 million in Q4 2025, with the low at $9.9 million in Q1 2023.
  • Average Non-Current Debt over 5 years is $18.5 million, with a median of $19.7 million recorded in 2024.
  • Year-over-year, Non-Current Debt plummeted 32.81% in 2023 and then soared 70.15% in 2024.
  • Tracing DERM's Non-Current Debt over 5 years: stood at $15.0 million in 2021, then surged by 32.42% to $19.8 million in 2022, then decreased by 26.25% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then increased by 1.6% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Non-Current Debt are $25.3 million (Q4 2025), $19.5 million (Q3 2025), and $21.4 million (Q2 2025).